Modulation of emesis by fentanyl and opioid receptor antagonists in Suncus murinus (house musk shrew)

European Journal of Pharmacology

Volumn 374, Issue 1, 1999, Pages 77-84

  Rudd, John A ^a   Cheng, Celine H K ^b   Naylor, Robert J ^b   Ngan, Man P ^a   Wai, Man K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

(Suncus murinus); Anti emesis; Opioid

Indexed keywords

16 METHYLCYPRENORPHINE; 17 METHYLNALOXONE; 17 METHYLNALOXONE BROMIDE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3 (2 METHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; 5,9 DIETHYL 2 (3 FURYLMETHYL) 2' HYDROXY 6,7 BENZOMORPHAN; ACETAMIDE DERIVATIVE; ANTIEMETIC AGENT; BUSPIRONE; DOMPERIDONE; FENTANYL; FLUPHENAZINE; GRANISETRON; METOCLOPRAMIDE; NALOXONAZINE; NALOXONE; NALTREXONE; NALTRINDOLE; NICOTINE; ONDANSETRON; OPIATE ANTAGONIST; PROMETHAZINE; SCOPOLAMINE; SULPIRIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; INSECTIVORE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VOMITING;

ANIMALS; ANTIEMETICS; FEMALE; FENTANYL; MALE; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; NICOTINE; RECEPTORS, OPIOID; SHREWS; VOMITING;

EID: 0033019766     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00285-X     Document Type: Article

References (55)

1. Barnes N.M., Bunce K.T., Naylor R.J., Rudd J.A. The actions of fentanyl to inhibit drug-induced emesis. Neuropharmacology. 30:1991;1073-1083.
2. Beleslin D.B., Krstic S.K. Further studies on nicotine-induced emesis: nicotinic mediation in area postrema. Physiology and Behavior. 39:1987;681-686.
3. Beleslin D.B., Krstic S.K., Stefarovie-Derik K., Strbac M., Micic D. Inhibition by morphine and morphine-like drugs of nicotine-induced emesis in cats. Brain Res. Bull. 6:1981;451-453.
4. Bhargava K.P., Dixit K.S., Gupta Y.K. Enkephaline receptors in the emetic chemoreceptor trigger zone of the dog. Br. J. Pharmacol. 72:1981;471-474.
5. Blancquaert J.P., Lefebvre R.A., Willems J.L. Emetic and antiemetic effects of opioids in the dog. Eur. J. Pharmacol. 128:1986;143-150.
6. Bountra C., Bunce K., Dale T., Gardner C., Jordan C., Twissell D., Ward P. Anti-emetic profile of a non-peptide neurokinin-NK(1) receptor antagonist, CP-99,994, in ferrets. Eur. J. Pharmacol. 249:1993;R3-R4.
7. Brown D.R., Goldberg L.I. The use of quaternary narcotic antagonists in opiate research. Neuropharmacology. 24:1985;181-191.
8. 3 receptors. Br. J. Pharmacol. 94:1988;397-412.
9. Calcagnetti D.J., Calcagnetti R.L., Fanselow M.S. Centrally administered opioid antagonists, nor-binaltorphimine, 16-methyl cyprenorphine and MR2266, suppress intake of a sweet solution. Pharmacol. Biochem. Behav. 35:1990;69-73.
10. Chang J.-J., Cuatrecasas P. Heterogeneity and properties of opiate receptors. Fed. Proc. 40:1981;2729-2734.
11. Christensen A.V., Arnt J., Svendsen O. Pharmacological differentiation of dopamine D-1 and D-2 antagonists after single and repeated administration. Psychopharmacology. 2:1985;182-190.
12. Costall B., Domeney A.M., Naylor R.J., Owera-Atepo J.B., Rudd J.A., Tattersall F.D. Fluphenazine, ICS 205-930 and DL-fenfluramine differentially antagonise drug-induced emesis in the ferret. Neuropharmacology. 29:1990;453-462.
13. Costello D.J., Borison H.L. Naloxone antagonizes narcotic self-blockade of emesis in the cat. J. Pharmacol. Exp. Ther. 203:1977;222-230.
14. Fowler C.J., Fraser G.L. μ-, δ-, κ-Opioid receptors and their subtypes. A critical review with emphasis on radioligand binding experiments. Neurochem. Int. 24:1994;401-426.
15. Goldberg S.R., Morse W.H., Goldberg D.M. Some behavioural effects of morphine, naloxone and nalorphine in the squirrel monkey and the pigeon. J. Pharmacol. Exp. Ther. 196:1976;625-636.
16. Gupta Y.K., Bhandari P., Chugh A., Seth S.D. Role of endogenous opioids and histamine in morphine induced emesis. Ind. J. Exp. Biol. 27:1989;52-54.
17. Hersom A.S., Mackenzie J. Opioid receptors involved in emesis in the dog. Br. J. Pharmacol. 92:1987;648P.
18. Hoyer, D., 1992. Agonists and antagonists at 5-HT receptor subtypes, In: Bradley, P.B., Handley, S.L., Cooper, S.J., Key, B.J., Barnes, N.M., Coote, J.H. (Eds.), Serotonin, CNS Receptors and Brain Function. Pergamon, Oxford, London, pp. 29-47.
19. Hulme E.C., Birdsall N.J.M., Buckley N.J. Muscarinic receptor subtypes. Annu. Rev. Pharmacol. Toxicol. 30:1990;633-673.
20. Jang Y., Yoburn B.C. Evaluation of receptor mechanisms mediating fentanyl analgesia and toxicity. Eur. J. Pharmacol. 197:1991;135-141.
21. Kakimoto S., Saito H., Matsuki N. Antiemetic effects of morphine on motion- and drug-induced emesis in Suncus murinus. Biol. Pharm. Bull. 20:1997;739-742.
22. King, G.L., Weatherspoon, J.K., 1992. Possible potentiation of the emetic response to oral S(-) zacopride by various receptor ligands in the ferret. In: Bianchi, A.L., Grélot, L., Miller, A.D., King, G.L. (Eds.), Mechanisms and Control of Emesis. Inserm/John Libbey Eurotext, Paris, France, pp. 217-226.
23. Kobrinsky N.L., Pruden P.B., Cheang M.S., Levitt M., Bishop A.J., Tenenbein M. Increased nausea and vomiting induced by naloxone in patients receiving cancer chemotherapy. Am. J. Pediatr. Oncol. 10:1988;206-208.
24. Laffan R.J., Borison H.L. Emetic action of nicotine and lobeline. J. Pharmacol. Exp. Ther. 121:1957;468-476.
25. Leslie F.M. Methods used for the study of opioid receptors. Pharm. Rev. 39:1987;197-249.
26. Leslie, R.A., Reynolds, D.J.M., 1993. Neurotransmitters and receptors in the emetic pathway. In: Andrews, P.L.R., Sanger, G.S. (Eds.), Emesis in Anti-Cancer Therapy Mechanisms and Treatment. Chapman & Hall Medical, London, UK, pp. 91-112.
27. 1A receptor agonists as anti-emetics. In: Reynolds, D.J.M., Andrews, P.L.R., Davis, C.J. (Eds.), Serotonin and the Scientific Basis of Anti-Emetic Therapy. Oxford Clinical Communications, Oxford, UK, pp. 222-227.
28. Matsuki, N., Torii, Y., Ueno, S., Saito, H., 1992. Suncus murinus as an experimental animal for emesis and motion sickness. In: Bianchi, A.L., Grélot, L., Miller, A.D., King, G.L. (Eds.), Mechanisms and Control of Emesis. Inserm/John Libbey Eurotext, Paris, France, pp. 323-329.
29. McCarthy L.E., Costello D.J., Borison H.L. Vomiting evoked by naloxone compared with apomorphine injected into the cerebrospinal fluid of cats. Fed. Proc. 23:1974;516.
30. McIntosh M., Kane K., Parratt J. Effects of selective opioid receptor agonists and antagonists during myocardial ischaemia. Eur. J. Pharmacol. 210:1992;37-44.
31. Mclean S., Ganong A., Seymour P.A., Snider R.M., Desai M.C., Rosen T., Bryce D.K., Longo K.P., Reynolds L.S., Robinson G., Schmidt A.W., Siok C., Heym J. Pharmacology of CP-99,994 - a nonpeptide antagonist of the tachykinin neurokinin-1 receptor. J. Pharmacol. Exp. Ther. 267:1993;472-479.
32. Miller A.D., Tan L.K., Suzuki I. Control of abdominal and expiratory intercostal muscle activity during vomiting: role of ventral respiratory group neurones. J. Neurophysiol. 57:1987;1854-1866.
33. Money K.E., Cheung B.S. Another function of the inner ear: facilitation of the emetic response to poisons. Aviat. Space Environ. Med. 54:1983;208-211.
34. 2 opioid binding in the mouse central nervous system. Brain Res. 360:1985;117-129.
35. Niemegeers C.J.E. Antiemetic specificity of dopamine antagonists. Psychopharmacology. 78:1982;210-213.
36. Niemegeers C.J.E., Schellekens K.H.L., Van Bever W.F.M., Janssen P.A.J. Sufentanil, a very potent and extremely safe intravenous morphine-like compound in mice, rats and dogs. Arzneim.-Forsch. 26:1976;1551-1556.
37. 1A-receptor agonists in Suncus murinus. Jpn. J. Pharmacol. 64:1994;109-114.
38. Paul D., Pasternak G.W. Differential blockade by naloxonazine of two μ opiate actions: analgesia and inhibition of gastrointestinal transit. Eur. J. Pharmacol. 149:1988;403-404.
39. Pearlman D.S. Antihistamines: pharmacology and clinical use. Drugs. 12:1976;258-273.
40. Portoghese P.S., Sultana M., Takemori A.E. Naltrindole, a highly selective and potent non-peptide ∂ opioid receptor antagonist. Eur. J. Pharmacol. 146:1988;185-186.
41. Pournaghash S., Riley A.L. Buprenorphine as a stimulus in drug discrimination learning: an assessment of mu and kappa receptor activity. Pharmacol. Biochem. Behav. 46:1993;593-604.
42. Rowbotham M.C., Joseph M.S., Jones R.T., Keil L.C. Failure of naloxone to reverse apomorphine effects in humans. Psychoneuroendocrinology. 8:1983;95-102.
43. Rudd, J.A., Naylor, R.J., 1992. Morphine-induced emesis in the ferret. In: Bianchi, A.L., Grélot, L., Miller, A.D., King, G.L. (Eds.), Mechanisms and Control of Emesis. Inserm/John Libbey Eurotext, Paris, France, pp. 351-352.
44. Rudd, J.A., Naylor, R.J., 1995. Opioid receptor involvement in emesis and anti-emesis. In: Reynolds, D.J.M., Andrews, P.L.R., Davis, C.J. (Eds.), Serotonin and the Scientific Basis of Anti-Emetic Therapy. Oxford Clinical Communications, Oxford, UK, pp. 208-219.
45. 1 receptor antagonists in Suncus murinus (house musk shrew). Eur. J. Pharmacol. 366:1999;243-252.
46. 3 receptor antagonism by BRL 43694 (granisetron). Eur. J. Pharmacol. 159:1989;113-124.
47. Schwartz R.W., Chang A.-A., Portogheses P.S., Berzetei-Gurske I.P. A guinea pig ileum preparation devoid of functional κ receptors: a new in vitro pharmacologic assay for μ-opioid ligands. Pharmacology Letters. 60:1997;235-239.
48. Selve N., Friderichs E., Reimann W., Reinartz S. Absence of emetic effects of morphine and loperamide in Suncus murinus. Eur. J. Pharmacol. 256:1994;287-293.
49. Sitsapesan R., Parratt J.R. The effects of drugs interacting with opioid receptors on the early ventricular arrhythmias arising from myocardial ischaemia. Br. J. Pharmacol. 97:1989;795-800.
50. 1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets. Neuropharmacology. 35:1996;1121-1129.
51. Van Giersbergen P.L.M., Palkovits M., De Jong W. Involvement of neurotransmitters in the nucleus tractus solitarii in cardiovascular regulation. Physiol. Rev. 72:1992;789-824.
52. Ventafridda V. Use of systemic analgesic drugs in cancer pain. Adv. Pain Res. Ther. 7:1984;557-574.
53. Watcha M.F., White P.F. Postoperative nausea and vomiting - its etiology, treatment, and prevention. Anesthesiology. 77:1992;162-184.
54. 1 receptor. Br. J. Pharmacol. 115:1995;84-94.
55. 3 receptor agonist, 7-OH-DPAT, causes vomiting in the dog. Life Sci. 57:1995;PL347-PL350.